{"id":1264,"date":"2026-01-27T14:30:18","date_gmt":"2026-01-27T14:30:18","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/01\/27\/developer-granted-patent-in-japan-for-masitinib-use-in-progressive-ms\/"},"modified":"2026-01-27T14:30:18","modified_gmt":"2026-01-27T14:30:18","slug":"developer-granted-patent-in-japan-for-masitinib-use-in-progressive-ms","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/01\/27\/developer-granted-patent-in-japan-for-masitinib-use-in-progressive-ms\/","title":{"rendered":"Developer granted patent in Japan for masitinib use in progressive MS"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/27\/ab-science-granted-patent-japan-covering-masitinib-use-progressive-ms\/\" title=\"Developer granted patent in Japan for masitinib use in progressive MS\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2025\/05\/ThumbsUpRepeated-1-800x400.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A line of hands flashes a thumbs-up sign.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"149594\" \/><\/a><\/p>\n<p>AB Science has received a patent in Japan covering the use of its investigational oral therapy masitinib for progressive forms of multiple sclerosis\u00a0(MS). The new patent \u2014 JP 7788154 \u2014 grants the France-based pharmaceutical company protection in the Asian nation through February 2041 on the use of masitinib for both primary progressive MS\u00a0(PPMS) and nonactive\u00a0secondary [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/27\/ab-science-granted-patent-japan-covering-masitinib-use-progressive-ms\/\">Developer granted patent in Japan for masitinib use in progressive MS<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/27\/ab-science-granted-patent-japan-covering-masitinib-use-progressive-ms\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AB Science has received a patent in Japan covering the use of its investigational oral therapy masitinib for progressive forms of multiple sclerosis\u00a0(MS). The new patent \u2014 JP 7788154 \u2014 grants the France-based pharmaceutical company protection in the Asian nation through February 2041 on the use of masitinib for both primary progressive MS\u00a0(PPMS) and nonactive\u00a0secondary&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1265,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1264","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1264"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1264\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1265"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}